The Effects of Thyrotropin-Suppressive Therapy on Bone Metabolism in Patients with Well-Differentiated Thyroid Carcinoma
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Patients with differentiated thyroid carcinoma (DTC) are commonly treated long-term with thyrotropin (TSH)- suppressive thyroxine replacement therapy resolving in a state of subclinical hyperthyroidism. The relationship between subclinical hyperthyroidism and osteoporosis is not clear. In this review, we systematically selected and analyzed 21 studies addressing this issue. Although multiple methodological differences between studies prevented a structured meta-analysis, our data suggest that postmenopausal women with subclinical hyperthyroidism are most at risk, whereas no increased risk was observed in men and premenopausal women. Based on these findings we believe that measurement of bone mineral density is recommended in postmenopausal women with DTC starting TSH suppressive therapy. This should be subsequently regularly measured to enable timely intervention with bone protective agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
TSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.
Burgess, T. L., Qian, Y.-X., Kaufman, S., Ring, B. D., Van, G., Capparelli, C., Kelley, M., Hsu, H., Boyle, W. J., Dunstan, C. R., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.527 · Cited by 689 · cited 1×
“RANKL increases the survival of RANK-positive T cells (21), promotes osteoclast differentiation (23–27), stimulates the activity of mature osteoclasts (24,28,29) and promotes survival of osteoclasts by preventing apoptosis (29).”
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398 · cited 1×
“This conclusion is in agreement with that of other reviews and metaanalyses addressing this issue (14;15; 55-57 ).”
Faber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Biondi, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4701 · Cited by 356
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8302 · Cited by 245 · cited 5×
“Subclinical hyperthyroidism has effects on carbohydrate metabolism (6), the cardiovascular system ( 7-11 ) and psychological well being (7;12).”
InfluentialThyroid hormone excess and glucose intolerance
Dimitriadis, G., & Raptis, S. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18584 · Cited by 179 · cited 1×
“The question that clearly is to be answered is whether long-term TSH-suppressive therapy is beneficial and safe in patients with DTC. Subclinical hyperthyroidism has effects on carbohydrate metabolism (6), the cardiovascular system (7–11) and psychological well-being (7,12).”
Cited by
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
Thyroid diseases and bone health
Williams, G. R., & Bassett, J. H. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0753-4 · Cited by 276
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Verloop, H., Louwerens, M., Schoones, J. W., Kievit, J., Smit, J. W. A., & Dekkers, O. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1063 · Cited by 220
Self-citationMurphy, E., Glüer, C. C., Reid, D. M., Felsenberg, D., Roux, C., Eastell, R., & Williams, G. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2630 · Cited by 180
Wang, L. Y., Smith, A. W., Palmer, F. L., Tuttle, R. M., Mahrous, A., Nixon, I. J., Patel, S. G., Ganly, I., Fagin, J. A., & Boucai, L. (2015) · Thyroid · doi:10.1089/thy.2014.0287 · Cited by 161
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138
Mazziotti, G., Porcelli, T., Patelli, I., Vescovi, P. P., & Giustina, A. (2010) · Bone · doi:10.1016/j.bone.2009.10.031 · Cited by 113
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy
Ito, M., Miyauchi, A., Hisakado, M., Yoshioka, W., Ide, A., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., Kobayashi, K., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0426 · Cited by 91
Thyroid Hormone Suppression Therapy
Biondi, B., & Cooper, D. S. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.008 · Cited by 81
Schneider, R., Schneider, M., Reiners, C., & Schneider, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2570 · Cited by 48
Reverter, J. L., Colomé, E., Holgado, S., Aguilera, E., Soldevila, B., Mateo, L., & Sanmartí, A. (2010) · Endocrine · doi:10.1007/s12020-010-9339-z · Cited by 37
Kwak, D., Ha, J., Won, Y., Kwon, Y., & Park, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043007 · Cited by 34
Mendonça Monteiro de Barros, G., Madeira, M., Vieira Neto, L., de Paula Paranhos Neto, F., Carvalho Mendonça, L. M., Corrêa Barbosa Lima, I., Corbo, R., & Fleiuss Farias, M. L. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0680-4 · Cited by 34
Shin, D. W., Suh, B., Lim, H., Yun, J. M., Song, S. O., & Park, Y. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3407 · Cited by 32
Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Kim, E. H., Jeon, Y. K., Pak, K., Kim, I.-J., Kim, S.-J., Shin, S., Kim, B. H., Kim, S. S., Lee, B.-J., Lee, J.-G., et al. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.1.31 · Cited by 26
Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy
Verburg, F. A., Smit, J. W. A., Grelle, I., Visser, T. J., Peeters, R. P., & Reiners, C. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04262.x · Cited by 14
Self-citationHong, A. R., & Kang, H.-C. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1701 · Cited by 15
Metadata
- Authors
- Heemstra, K. A., Hamdy, N. A. T., Romijn, J. A., & Smit, J. W. A.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2006-06
- Volume
- 16
- Issue
- 6
- Pages
- 583-591
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1970453763
- Cited by
- 134
- References
- 17
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.